Analysis of the Correlation between Hypercholesterolemia and Increased Cardiovascular Morbidity and Mortality among

Noam Nagel1, Ruth Rahamimov1,2,3, Dana Bielopolski1,2

  • 1Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

PubMed

Insights

A high LDL-C/HDL-C ratio predicts increased cardiovascular risk in kidney transplant recipients (KTRs). This finding highlights the ratio

Area of Science:

  • Nephrology
  • Cardiology
  • Transplantation Medicine

Background:

  • Hypercholesterolemia's impact on cardiovascular disease (CVD) in kidney transplant recipients (KTRs) is not well-defined.
  • Characterizing cholesterol profiles and their association with CVD in KTRs is crucial.

Purpose of the Study:

  • To investigate the correlation between abnormal cholesterol levels and cardiovascular morbidity and mortality in KTRs.
  • To identify specific lipid markers predictive of adverse cardiovascular outcomes in this population.

Main Methods:

  • Retrospective cohort study of 737 adult KTRs transplanted between 2005 and 2014.
  • Primary outcome: Major Adverse Cardiovascular Events (MACE). Secondary outcome: MACE and all-cause mortality.
  • Multivariate time-varying Cox models analyzed MACE and mortality risk based on time-weighted average cholesterol levels.

Main Results:

  • High LDL-C levels correlated with increased MACE risk (HR 1.008 per mg/dL).
  • Low HDL-C levels showed no significant association with MACE (HR 0.992 per mg/dL).
  • A higher LDL-C/HDL-C ratio significantly increased MACE risk (HR 1.502 per unit) and the composite outcome (HR 1.35 per unit).

Conclusions:

  • The LDL-C/HDL-C ratio is a significant predictor of cardiovascular morbidity and mortality in KTRs.
  • This ratio serves as a valuable marker for cardiovascular risk assessment in KTRs.
  • Findings support interventions to manage hypercholesterolemia in this high-risk group.
Abstract

Related Concept Videos

Kidney Transplant I: Introduction01:28

Kidney Transplant I: Introduction

A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
2
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
2
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage kidney disease (ESKD). At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate...
2
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
2
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
2
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
3